摘要:
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
摘要:
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
摘要:
Disclosed are a sensor, a cooking apparatus having the sensor, and a control method of the cooking apparatus. The sensor serves to accurately sense a pollution level of the cooking apparatus and to inform of a cleaning time and/or cleaning method based on the pollution level. The pollution level of a cooking compartment may be objectively determined using the sensor that senses the pollution level via a variation of capacitance. Also, it may be possible to guide a cleaning time and/or cleaning method (e.g., manual cleaning, steam cleaning, thermal decomposition cleaning, etc.) based on the pollution level of the cooking compartment, allowing the cooking compartment to be cleaned in the cleaning method at an appropriate cleaning time. In particular, during a thermal decomposition cleaning operation, the pollution level is sensed in real time to enable variable control the cleaning time and automatic control of a cleaning ending time. This may contribute to reduce energy consumption and discharge of CO2.
摘要:
Disclosed is a lyophilized preparation of recombinant factor VIII used as a therapeutic preparation of hemophilia A. The lyophilized preparation of recombinant factor VIII is prepared by performing lyophilization using a mixture comprising 6 to 100 mM of L-arginine, 3.5 to 50 mM of L-isoleucine, and 10 to 100 mM of L-glutamic acid as a stabilizer for stabilizing the recombinant factor VIII which exhibits an unstable activity during lyophilization, rather than using human blood derived albumin.